CRL Earnings Charles River Laboratories
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-28 | -0.30 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-27 | -2.91 | 2026-02-18 | 10-K |
| Q3 2025 | 2025-09-27 | 2.65 | 2025-11-05 | 10-Q |
| Q2 2025 | 2025-06-28 | 1.55 | 2025-08-06 | 10-Q |
| Q1 2026 | 2025-03-29 | 0.50 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-28 | 0.20 | 2026-02-18 | 10-K |
| Q3 2025 | 2024-09-28 | 4.37 | 2025-11-05 | 10-Q |
| Q2 2025 | 2024-06-29 | 3.04 | 2025-08-06 | 10-Q |
| Q1 2025 | 2024-03-30 | 1.30 | 2025-05-07 | 10-Q |
| FY 2025 | 2023-12-30 | 9.22 | 2026-02-18 | 10-K |
| Q3 2024 | 2023-09-30 | 5.58 | 2024-11-06 | 10-Q |
| Q2 2024 | 2023-07-01 | 3.90 | 2024-08-07 | 10-Q |
| Q1 2024 | 2023-04-01 | 2.01 | 2024-05-09 | 10-Q |
| FY 2024 | 2022-12-31 | 9.48 | 2025-02-19 | 10-K |
| Q3 2023 | 2022-09-24 | 5.83 | 2023-11-08 | 10-Q |
| Q2 2023 | 2022-06-25 | 3.94 | 2023-08-09 | 10-Q |
| Q1 2023 | 2022-03-26 | 1.81 | 2023-05-11 | 10-Q |
| FY 2023 | 2021-12-25 | 7.60 | 2024-02-14 | 10-K |
| Q3 2022 | 2021-09-25 | 4.93 | 2022-11-02 | 10-Q |
| Q2 2022 | 2021-06-26 | 2.93 | 2022-08-03 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.